Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEPTIME: Emotional Disorders in RRMS with Interferon Beta
NCT01201343Phase 4Completed
- Sponsor
- Merck KGaA
- Start
- Jan 2005
- Primary completion
- Jul 2010
- Modality
- Cytokines & Interferons
01
Overview
A Phase 4 trial of interferon beta-1a in relapsing-remitting multiple sclerosis (RRMS), sponsored by Merck KGaA. Started Jan 2005; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT01201343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01201343.